Product Information
MORPHINE SULF 100 MG/5 ML CONC is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.3920 per ML under NDC 27808008201. Its NADAC has been published 569 times since Nov 11, 2015.
FDA first approved this application on May 12, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 mg/mL
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808008201
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203518FDA Approved
5/12/2015
TE Code
AA
On Market Since
9/21/2015
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF 100 MG/5 ML CONC has been published 569 times since Nov 11, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3920 per ML |
|---|---|
| All-time high | $0.4255 (Mar 11, 2026) |
| All-time low | $0.2833 (Feb 20, 2019) |
| 52-week high | $0.4255 |
| 52-week low | $0.3920 |
| Median price | $0.3387 |
| Average price | $0.3431 |
| Largest weekly change | -19.8% (Dec 23, 2020) |
| Weeks tracked | 569 |
| Tracking since | Nov 11, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULF 100 MG/5 ML CONC?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF 100 MG/5 ML CONC, manufactured by Cranbury Pharmaceuticals, LLC, is $0.3920 per ML (NDC 27808008201), effective Sep 30, 2026.
How has the price of MORPHINE SULF 100 MG/5 ML CONC changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF 100 MG/5 ML CONC has held within roughly two percent of its current level. It has been tracked across 569 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF 100 MG/5 ML CONC?
Since Nov 11, 2015, the NADAC for MORPHINE SULF 100 MG/5 ML CONC has ranged from a low of $0.2833 (Feb 20, 2019) to a high of $0.4255 (Mar 11, 2026), with a median of $0.3387 per ML.
Are there cheaper alternatives to MORPHINE SULF 100 MG/5 ML CONC?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULF 20 MG/5 ML SOLN, is $0.0682 per ML — about 83% below MORPHINE SULF 100 MG/5 ML CONC.
Who manufactures MORPHINE SULF 100 MG/5 ML CONC?
MORPHINE SULF 100 MG/5 ML CONC (NDC 27808008201) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.